Received Jan 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
sinuses and throat to fill up with mucus; sinuses and throat to fill up with mucus; uncomfortable; This non-serious case was reported by a consumer via call center representative and described the occurrence of sinus congestion in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. In JAN-2026, an unknown time after receiving Shingrix, the patient experienced sinus congestion (Verbatim: sinuses and throat to fill up with mucus), throat secretion increased (Verbatim: sinuses and throat to fill up with mucus) and discomfort (Verbatim: uncomfortable). The outcome of the sinus congestion, throat secretion increased and discomfort were not resolved. The reporter considered the sinus congestion, throat secretion increased and discomfort to be related to Shingrix. The company considered the sinus congestion, throat secretion increased and discomfort to be related to Shingrix. Additional Information: GSK Receipt Date: 16-JAN-2026 The reporter stated that the vaccine caused sinuses and throat of the patient to fill up with mucus. The patient had been dealing with this for three days by the day of reporting and was feeling really uncomfortable The batch number was not provided and a request for this information has been made. This case is linked with case US2026AMR008381, reported by the same reporter.; Sender's Comments: US-GSK-US2026AMR008381:Same Reporter